Antibody-mediated rejection of single class i MHC-disparate cardiac allografts

American Journal of Transplantation

Volumn 12, Issue 8, 2012, Pages 2017-2028

  Hattori, Y ^a,b,c   Bucy, R P ^d   Kubota, Y ^c   Baldwin Iii, W M ^a,b   Fairchild, R L ^a,b,e  

^a Glickman Urological and Kidney Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

animal models; Antibody mediated rejection; basic science; biomarker; cardiac transplant; graft rejection; leukocyte infiltration; neutrophils

Indexed keywords

ANTIBODY; COMPLEMENT MEMBRANE ATTACK COMPLEX; DIAMINOBENZIDINE; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; PERFORIN; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CAPILLARY; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT SURVIVAL; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODY FORMATION; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL5; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERFORIN; PEROXIDASE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864435577     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04073.x     Document Type: Article

References (45)

1. Colvin RB, Smith RN,. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817.
2. Racusen LC, Colvin RB, Solez K, et al,. Antibody-mediated rejection criteria-an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
3. Takemoto SK, Zeevi A, Feng S, et al,. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041.
4. Uber WE, Self SE, van Bakel AB, Pereira NL,. Acute antibody-mediated rejection following heart trasnplantation. Am J Transplant 2007; 7: 2064-2074.
5. Crespo M, Pascual M, Tolkoff-Rubin N, et al,. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658.
6. Pollinger HS, Stegall MD, Gloor JM, et al,. Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 2007; 7: 857-863.
7. Gloor JM, Sethi S, Stegall MD, et al,. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132.
8. Langan LL, Park LP, Hughes TL, et al,. Post-tranplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 2007; 7: 847-856.
9. Campos EF, Tedesco-Silva H, Machado PG, Franco M, Medina-Pestana JO, Gerbase-DeLima M,. Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006; 6: 2316-2320.
10. Gloor J, Cosio F, Lager DJ, Stegall MD,. The spectrum of antibody-mediated renal allograft injury: Implications for treatment. Am J Transplant 2008; 8: 1367-1373.
11. Taflin C, Charron D, Glotz D, Mooney N,. Immunological function of the endothelial cell within the setting of organ transplantation. Immunol Lett 2011; 139: 1-6.
12. Zhang X, Reed EF,. Effect of antibodies on endothelium. Am J Transplant 2009; 9: 2459-2465.
13. Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WMI, Wasowska BA,. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004; 4: 326-334.
14. Wasowska BA, Qian Z, Cangellow DLB, et al,. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 2001; 71: 727-736.
15. Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM,. Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 2002; 169: 4620-4627.
16. Albrecht EA, Chinnaiyan AM, Varambally S, et al,. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 2004; 164: 849-859.
17. Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, Fontaine MC,. Regulation of complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 2003; 17: 1003-1014.
18. Saadl S, Holzknecht RA, Patte CP, Platt JL,. Endothelial cell activation by pore-forming structures: Pivotal role for interleukin-1a. Circulation 2000; 101: 1867-1873.
19. Saadl S, Platt JL,. Humoral rejection and endothelial cell activation. Xenotransplantation 2002; 9: 239-241.
20. -/- recipients. Am J Transplant 2008; 8: 557-566.
21. Nozaki T, Amano H, Bickerstaff A, et al,. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J Immunol 2007; 179: 5238-5245.
22. Honjo K, Xu XY, Kapp JA, Bucy RP,. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4+ TCR Tg T cells specific for a defined allopeptide. Am J Transplant 2004; 4: 1762-1768.
23. Corry RJ, Winn HJ, Russell PS,. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 6; 343-350.
24. Setoguchi K, Schenk AD, Ishi D, et al,. LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am J Transplant 2011; 11: 923-935.
25. Schenk AD, Nozaki T, Rabant M, Valujskikh A, Fairchild RL,. Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients. Am J Transplant 2008; 8: 1652-1661.
26. Afanasyeva M, Georgakopoulos D, Belardi DF, et al,. Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: Correlation with cardiac function. Am J Pathol 2004; 164: 807-815.
27. Murata K, Fox-Talbot K, Qian Z, et al,. Synergistic depostiion of C4d by complement-activating and non-activaing antibodies in cardiac transplants. Am J Trasnplant 2007; 7: 2605-2614.
28. Nozaki T, Rosenblum JM, Schenk AD, Ishii D, Fairchild RL,. CCR5 is required for regulation of alloreactive T cell responses to single class II MHC-mismatched murine cardiac grafts. Am J Transplant 2009; 9: 2251-2261.
29. + T cells. J Immunol 2005; 174: 3741-3748.
30. Halloran PF, Schlaut J, Solez K, Srinivasa NS,. The significance of the anti-class I antibody response. II. Clinical and pathologic features of renal transpalntas with anti-class I-like antibody. Transplantation 1992; 53: 550-555.
31. McKenna RM, Takemoto SK, Terasaki PI,. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326.
32. Tambur AR, Pamboukian SV, Costanzo MR, et al,. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 2005; 80: 1019-1025.
33. Terasaki PI,. Humoral theory of transplantation. Am J Transplant 2003; 3: 665-673.
34. Lee P-C, Terasaki PI, Takemoto SK, et al,. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74: 1192-1194.
35. Reed EF, Demetris AJ, Hammond E, et al,. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153-159.
36. Mauiyyedi S, Crespo M, Collins AB, et al,. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779-787.
37. Moll SPM,. Humoral rejection of organ allografts. Am J Transplant 2005; 5: 2611-2618.
38. Hidalgo LG, Sis B, Sellares J, et al,. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvment in antibody-mediated rejection. Am J Transplant 2010; 10: 1812-1822.
39. Hirohashi T, Chase CM, Della Pelle P, et al,. A novel pathway of chronic allograft rejection mediaed by NK cells and alloantibody. Am J Transplant 2012; 12: 313-321.
40. Uehara S, Chase CM, Kitchens WH, et al,. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 3424-3230.
41. Asgari E, Zhou W, Sacks S,. Complement in organ transplantation. Curr Opin Organ Transplant 2010; 15: 486-491.
42. Brodsky SV, Nadasdy GM, Pelletier R, et al,. Expression of the decay-accelerating factor (CD55) in renal transplants-a possible preduction marker of allograft survival. Transplantation 2009; 88: 457-464.
43. Tan CD, Sokos GG, Pidwell DJ, et al,. Correlation of donor-specific antibodies, complement and its regulators with gaft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 2009; 9: 2075-2084.
44. Baggiolini M, Dewald B, Moser B,. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
45. Olson TS, Ley K,. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physol Regul Integr Comp Physiol 2002; 283: R7-R28.